Skip to main navigation
Skip to Content
logo

Live - Investor Relations & Corporate Menu

  • Science
    • Simufilam
    • SavaDx
    • Publications
    • Clinical Trials
  • News
  • About
    • Management
    • Board of Directors
    • Governance Documents
    • Contact Us
    • FCOI Policy
    • Legal Notice
    • Terms of Use
    • Clinical Trials
  • Investors
    • Company Presentations
    • Financial Information
      • SEC Filings
      • Annual Reports
  • Clinical Trials
    • rethinkALZ
    • refocusALZ
    • Connect Me With A Study Doctor
    • Expanded Access
  • We're Hiring
  • Resources
Sign Up for Alerts Connect Me With a Study Doctor

Company Presentations

Company Presentations

Presentations

Cassava Corporate Presentation – January 2023 2 MB
CTAD 2022 Poster 1.2 MB
CTAD 2021 Poster 340.6 KB
Statement Regarding Allegations Against Cassava Sciences, Inc.
Sep 3, 2021
Public Statement – September 3, 2021 305 KB
Journal of Neuroscience – November 4, 2021 274.3 KB
Neuroscience [Journal] – December 21, 2021 305.2 KB
Citizen Petition Denied – February 10, 2022 261.6 KB
Media Reports Response – July 27, 2022 344.1 KB
JPAD – August 18, 2022 364.6 KB

Past Events

Cassava Sciences at the H.C. Wainwright Annual Global Investment Conference
Sep 13, 2022
3:30 PM EDT
Click here for webcast

Shareholder Tools - ACTIVE

Print Page
Sign Up for Alerts
RSS News Feeds
Contact Us
  • © 2023 Cassava Sciences, Inc.

Live - Investor Relations & Corporate Menu

  • Science
  • News
  • About
  • Investors
  • Clinical Trials
  • We're Hiring
  • Resources